TH.TO vs. ANRG.TO

Last updated Jun 4, 2026

TH.TO (Theratechnologies Inc.) and ANRG.TO (Anaergia Inc.) are both stocks. TH.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare), while ANRG.TO operates in Waste Management (Industrials). At a 0.06 correlation, their price movements are largely independent.

Performance

TH.TO vs. ANRG.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Theratechnologies Inc. (TH.TO) and Anaergia Inc. (ANRG.TO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

TH.TO

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ANRG.TO

• 1D: -2.79%
• 1M: -7.92%
• YTD: 23.45%
• 6M: 17.72%
• 1Y: 119.69%
• 3Y*: 52.29%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TH.TO vs. ANRG.TO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TH.TO Theratechnologies Inc.	0.00%	70.61%	22.43%	-55.42%	-68.59%	-16.59%
ANRG.TO Anaergia Inc.	23.45%	140.43%	276.00%	-94.24%	-78.51%	45.01%

Correlation

The correlation between TH.TO and ANRG.TO is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.05
Correlation (All Time) Calculated using the full available price history since Jun 21, 2021	0.06

Fundamentals

Market Cap TH.TO : CA$220.65M ANRG.TO : CA$478.22M
Total Revenue (TTM) TH.TO : CA$84.38M ANRG.TO : CA$210.55M
Gross Profit (TTM) TH.TO : CA$65.58M ANRG.TO : CA$45.32M
EBITDA (TTM) TH.TO : CA$2.05M ANRG.TO : CA$2.05M

Return for Risk

TH.TO vs. ANRG.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANRG.TO

ANRG.TO Risk / Return Rank: 83
ANRG.TO Sharpe Ratio Rank: 87
ANRG.TO Sortino Ratio Rank: 84
ANRG.TO Omega Ratio Rank: 80
ANRG.TO Calmar Ratio Rank: 84
ANRG.TO Martin Ratio Rank: 81

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TH.TO vs. ANRG.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Theratechnologies Inc. (TH.TO) and Anaergia Inc. (ANRG.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	TH.TO	ANRG.TO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.89	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.29	—

Drawdowns

Drawdown Indicators

	TH.TO	ANRG.TO	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.17%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-36.66%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-88.38%	—
Current Drawdown Current decline from peak	—	-89.25%	—
Average Drawdown Average peak-to-trough decline	—	-79.18%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	17.68%	—

Volatility

Volatility by Period

	TH.TO	ANRG.TO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.69%	—
Volatility (6M) Calculated over the trailing 6-month period	—	43.69%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	63.99%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	94.69%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	94.69%	—

Dividends

TH.TO vs. ANRG.TO - Dividend Comparison

Neither TH.TO nor ANRG.TO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

TH.TO vs. ANRG.TO - Profitability Comparison

The chart below illustrates the profitability comparison between Theratechnologies Inc. and Anaergia Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

TH.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Theratechnologies Inc. reported a gross profit of 13.03M and revenue of 17.73M. Therefore, the gross margin over that period was 73.5%.

ANRG.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Anaergia Inc. reported a gross profit of 10.71M and revenue of 55.23M. Therefore, the gross margin over that period was 19.4%.

TH.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Theratechnologies Inc. reported an operating income of -1.90M and revenue of 17.73M, resulting in an operating margin of -10.7%.

ANRG.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Anaergia Inc. reported an operating income of -1.56M and revenue of 55.23M, resulting in an operating margin of -2.8%.

TH.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Theratechnologies Inc. reported a net income of -4.46M and revenue of 17.73M, resulting in a net margin of -25.2%.

ANRG.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Anaergia Inc. reported a net income of -1.83M and revenue of 55.23M, resulting in a net margin of -3.3%.

Frequently Asked Questions

Can I hold both TH.TO and ANRG.TO in my portfolio?

TH.TO and ANRG.TO have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.